DrugPatentWatch

Competitive intelligence on small-molecule drugs and the 80,000 patents covering them

Simple flat-rate subscription plans

Ultimate Plan

$495/ month or  $2,495/ year

Tradename: EXPAREL

Summary for Tradename: EXPAREL

Patents:2
Applicants:1
NDAs:1
Suppliers: see list1
drug
patent expirations by year for
 EXPAREL

Pharmacology for Tradename: EXPAREL

Ingredient-typeAmides
Drug ClassAmide Local Anesthetic
Physiological EffectLocal Anesthesia

Clinical Trials for: EXPAREL

EXPAREL Infiltrated Into the TAP for Postoperative Analgesia in Unilateral Abdominal Hernia Repair
Status: Completed Condition: Hernia

The Effect of Exparel on Post Operative Pain and Narcotic Use After Colon Surgery
Status: Completed Condition: Post-operative Pain; Colon Cancer; Diverticulitis

Exparel in Minimally Invasive Cardiac Surgery
Status: Recruiting Condition: Cardiac Disease

EXPAREL Administered Into the TAP for Analgesia in Subjects Undergoing Open Total Abdominal Hysterectomy
Status: Terminated Condition: Postoperative Pain

Exparel vs. Standard Bupivicaine for Abdominoplasty
Status: Terminated Condition: Pain, Postoperative

Liposomal Bupivacaine (Exparel) for Postoperative Pain Control for Open and Laparoscopic Abdominal Hernia Repair
Status: Recruiting Condition: Pain

TAP-patients With Robotic Assisted Lap Prostatectomy
Status: Completed Condition: Postsurgical Pain; Analgesia; Prostatectomy

Pharmacokinetic Evaluation of EXPAREL in Adults Undergoing Tonsillectomy
Status: Recruiting Condition: Adult Tonsillectomy; Pain

EXPAREL Administered by Infiltration Into the TAP for Prolonged Postsurgical Analgesia in Lower Abdominal Surgeries
Status: Terminated Condition: Postsurgical Analgesia

Evaluation Exparel Delivered in Knee Replacement
Status: Recruiting Condition: Arthritis

Courtesy of ClinicalTrials.org
See more clinical trials for this drug
Glossary
Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Pacira Pharms Inc
EXPAREL
bupivacaine
INJECTABLE, LIPOSOMAL;INJECTION022496Oct 28, 2011DISCNNo<disabled><disabled>
Pacira Pharms Inc
EXPAREL
bupivacaine
INJECTABLE, LIPOSOMAL;INJECTION022496Oct 28, 2011DISCNNo6,132,766<disabled>Y<disabled>
Pacira Pharms Inc
EXPAREL
bupivacaine
INJECTABLE, LIPOSOMAL;INJECTION022496Oct 28, 2011DISCNNo8,182,835<disabled>Y<disabled>
Pacira Pharms Inc
EXPAREL
bupivacaine
INJECTABLE, LIPOSOMAL;INJECTION022496Oct 28, 2011RXYes<disabled><disabled>
This preview shows a limited data set
Complete access is available with a Subscription
first patents previous patents next patents last patents

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

DrugPatentWatch Archives

You are viewing the current data set
Select a link below to view the archives:

 2000  2001  2002  2003  2004  2005  2006  2007  2008  2009 
 2010  2011  2012  2013 

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.

Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided information. There is no warranty that the information contained herein is error free. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Connect with Social Media:

Follow DrugPatentWatch on Twitter Connect with DrugPatentWatch on Linkedin Drug Patents on LinkedIn

Copyright © 2002-2014 thinkBiotech LLC. ISSN: 2162-2639

Other thinkBiotech sites: BiotechUBiotechBlogJournal of Commercial Biotechnology

`abc